SUMITOMO PHARMA CO., LTD.
March 2, 2015
Sumitomo Dainippon Pharma Co., Ltd.
Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; President: Masayo Tada) today announced that the following organizational realignment and changes related to its officers and other key positions will take place effective April 1, 2015:
I. Organizational Realignment (effective April 1, 2015)Corporate Departments
1. Career Development Support is renamed Career Development.
2. Information Systems Planning is renamed Corporate IT Management.
3. The Japanese-language naming of International Business Management is changed.
Corporate Regulatory Compliance & Quality Assurance (Division)
Global Regulatory Compliance Management is dissolved.
Sales & Marketing (Division)
1. Oncology Marketing Unit is created. *
2. Psychiatry regions belonging to Divisions "Higashi-Nippon Region" and "Nishi-Nippon Region"
are dissolved and Psychiatry Groups are created in Branches.
* Sales and marketing teams are reorganized to strengthen the base for oncology area in anticipation of the launch of anti-cancer drugs (BBI608 and BBI503) in Japan targeted for fiscal years 2017 and 2018.
(1) New appointments (effective April 1, 2015) Executive Officer
Toru Kimura (currently Director, Regenerative & Cellular Medicine Office)
Executive Officer
Hajime Kinuta (currently Director, Global Corporate Planning)
1
(2) Changes in the posts assumed by Executive Officers (effective April 1, 2015)
Post as of April 1, 2015 | Current post | Name |
Member, Board of Directors, Executive Vice President Sales & Marketing; Legal Affairs; Intellectual Property; International Business Management | Member, Board of Directors, Executive Vice President Sales & Marketing; Legal Affairs; Intellectual Property; International Business Management | Makoto Hara |
Senior Executive Officer Sunovion Pharmaceuticals Inc. | Senior Executive Officer Sunovion Pharmaceuticals Inc.; Head of Global Clinical Development for Sumitomo Dainippon Pharma Group | Nobuhiko Tamura |
Executive Officer Executive Director, Technology Research & Development; Corporate IT Management | Executive Officer Executive Director, Technology Research & Development; Information Systems Planning | Yoshiharu Ikeda |
Executive Officer Director, Personnel; Career Development | Executive Officer Director, Personnel; Career Development Support | Hitoshi Odagiri |
Executive Officer Sunovion Pharmaceuticals Inc.; Head of Global Clinical Development for Sumitomo Dainippon Pharma Group | Executive Officer Sunovion Pharmaceuticals Inc. | Antony Loebel |
Corporate Departments
Position as of April 1, 2015 | Current position | Name |
Director, Career Development | Deputy Executive Director, Sales & Marketing | Toru Nakatsuka |
Director, Corporate IT Management | Director, Information Systems Planning | Kyoichi Yokota |
Director, International Business Management | Director, International Business Management | Atsuko Higuchi |
Corporate Regulatory Compliance & Quality Assurance (Division)
Position as of April 1, 2015 | Current position | Name |
Director, Regulatory Compliance & Quality Assurance Management | Director, Clinical & Research Quality Assurance | Yuko Fujiwara |
Director, Clinical & Research Quality Assurance | Director, Global Regulatory Compliance Management | Fumio Samizo |
Drug Development (Division)
Position as of April 1, 2015 | Current position | Name |
Director, Medical Affairs | Director, Kyushu-minami Branch, Nishi-Nippon Region | Takayuki Funabe |
2
Director, Clinical Research | Group Manager, Development Regulatory Affairs Group, Clinical Research | Yumi Sato |
Director, Clinical Operation | Director, Oncology Clinical Development Unit | Tsukasa Kiriyama |
Director, Oncology Clinical Development Unit | Group Manager, Development Management Group, Project Management Group Manager, Clinical Research & Medical Affairs Group, Oncology Clinical Development Unit | Haruhiko Koike |
Sales & Marketing (Division)
Position as of April 1, 2015 | Current position | Name |
Deputy Executive Director, Sales & Marketing | Director, Distribution Management | Shinjiro Takayama |
Deputy Executive Director, Sales & Marketing | Director, Personnel Development | Akira Yamagishi |
Director, Product Management & Promotion Planning | Director, CNS Product Management & Promotion Planning | Yukako Nishimaki |
Director, CNS Product Management & Promotion Planning | Director, Psychiatry Kinki-Tokai Region, Nishi-Nippon Region | Fukio Kanai |
Director, Personnel Development | Deputy Director, Personnel | Ichiro Takahashi |
Director, Distribution Management | Director, Hokuriku Branch, Nishi-Nippon Region | Toshinobu Shiina |
Director, Oncology Marketing Unit | Deputy Director, Global Oncology Office | Masayuki Uchibori |
Director, Chiba Branch, Higashi-Nippon Region | Director, Psychiatry Higashi-Nippon Region, Higashi-Nippon Region | Ichiro Nagaoka |
Director, Tokyo Branch II, Higashi-Nippon Region | Director, Psychiatry Capital Region, Higashi-Nippon Region | Tsuneharu Inoue |
Director, Hokuriku Branch, Nishi-Nippon Region | Director, Chugoku Branch, Nishi-Nippon Region | Hiroshi Tsujino |
Director, Chugoku Branch, Nishi-Nippon Region | Director, Chiba Branch, Higashi-Nippon Region | Hisayuki Ichikawa |
Director, Kyushu-minami Branch, Nishi-Nippon Region | Director, Psychiatry Nishi-Nippon Region, Nishi-Nippon Region | Osamu Yamamoto |
Contact:
Corporate Communications Sumitomo Dainippon Pharma TEL: +81-6-6203-1407 (Osaka)
+81-3-5159-3300 (Tokyo)
3
|
distributed by
|
